Middle East Respiratory Syndrome
Yaseen M. Arabi(King Saud bin Abdulaziz University for Health Sciences), Robert Fowler(Mount Sinai Hospital), Ali H. Hajeer(King Saud bin Abdulaziz University for Health Sciences), J. Kenneth Baillie(Roslin Institute), Awad Al‐Omari(Alfaisal University), Frederick G. Hayden(University of Virginia), Mikiko Senga(King Saud bin Abdulaziz University for Health Sciences), Hanan H. Balkhy(King Saud bin Abdulaziz University for Health Sciences), Abderrezak Bouchama(King Saud bin Abdulaziz University for Health Sciences), Mark R. Denison(King Saud bin Abdulaziz University for Health Sciences), Maria D. Van Kerkhove(World Health Organization), James D. Chappell(King Saud bin Abdulaziz University for Health Sciences), Nahoko Shindo(World Health Organization - Pakistan), Thomas Luke(King Saud bin Abdulaziz University for Health Sciences), Alison Bermingham(King Saud bin Abdulaziz University for Health Sciences), Jonathan S. Nguyen‐Van‐Tam(King Saud bin Abdulaziz University for Health Sciences)
Cited by 511
Related Papers
Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021
|Intensive Care Medicine|2021|5k
Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial
|The Lancet|2020|3.7k
Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock 2021
|Critical Care Medicine|2021|2.7k
Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial
|The Lancet|2020|2.6k
A minimal common outcome measure set for COVID-19 clinical research
|The Lancet Infectious Diseases|2020|1.8k